Landscapes / Companies
Shattuck Labs, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 5 in all
Trials
2 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Feb 2028Phase 2 trial completes | |||
| Next date | Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | Crohn's Disease, Hidradenitis Suppurativa (HS) | ||||
| Open drug page | |||||
About
- No active trial
- Mirvetuximab + SL-172154, Pegylated Liposomal Doxorubicin, SL-172154, SL-279252
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021